eFFECTOR Therapeutics, Inc.

📍 Solana Beach, United States🗓 Founded 2012👥 27 employees💰 Last funded Apr 2019
Biotechnology🌐 effector.com
Website LinkedIn
eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs). Translation is the process in cells whereby the synthesis of proteins is directed by information contained in genetic sequences. Each of eFFECTOR’s product candidates is designed to act on a single protein that regulates, in a coordinated manner, the expression of multiple functionally related proteins that together drive important biological processes such as immune evasion, stress and inflammatory responses, as well as cell proliferation.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in eFFECTOR Therapeutics, Inc.?
eFFECTOR Therapeutics, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did eFFECTOR Therapeutics, Inc. last raise funding?
The most recent investment in eFFECTOR Therapeutics, Inc. recorded on gritt.io was in April 2019.
When was eFFECTOR Therapeutics, Inc. founded?
eFFECTOR Therapeutics, Inc. was founded in 2012.
What industry is eFFECTOR Therapeutics, Inc. in?
eFFECTOR Therapeutics, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is eFFECTOR Therapeutics, Inc. based?
eFFECTOR Therapeutics, Inc. is headquartered in Solana Beach, United States.